Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes
- PMID: 18566103
- DOI: 10.1189/jlb.1107729
Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes
Abstract
Mononuclear phagocytes (MPCs) at the tumor site can be divided into subclasses, including monocyte-lineage myeloid-derived suppressor cells (MDSCs) and the immunosuppressive tumor-infiltrating macrophages (TIMs). Cancer growth coincides with the expansion of MDSCs found in the blood, secondary lymphoid organs, and tumor tissue. These MDSCs are thought to mature into macrophages and to promote tumor development by a combination of growth-enhancing properties and suppression of local antitumor immunoresponses. As little is known about either subset of MPCs, we investigated MPCs infiltrating into murine adenocarcinoma MCA38 tumors. We found that these MPCs displayed immunosuppressive characteristics and a MDSC cell-surface phenotype. Over 70% of the MPCs were mature (F4/80(+)Ly6C(-)) macrophages, and the rest were immature (F480(+) Ly6C(+)) monocytes. MPC maturation was inhibited when the cells infiltrated a tumor variant expressing IL-2 and soluble TNF type II receptor (sTNFRII). In addition, the IL-2/sTNFRII MCA38 tumor microenvironment altered the MPC phenotype; these cells did not survive culturing in vitro as a result of Fas-mediated apoptosis and negligible M-CSFR expression. Furthermore, CD4(+) tumor-infiltrating lymphocytes (TILs) in wild-type tumors robustly expressed IL-13, IFN-gamma, and GM-CSF, and CD4(+) TILs in IL-2/sTNFRII-expressing tumors expressed little IL-13. These data suggest that immunotherapy-altered Th cell balance in the tumor microenvironment can affect the differentiation and maturation of MPCs in vivo. Furthermore, as neither the designation MDSC nor TIM can sufficiently describe the status of monocytes/macrophages in this tumor microenvironment, we believe these cells are best designated as MPCs.
Similar articles
-
Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics.J Leukoc Biol. 2008 May;83(5):1136-44. doi: 10.1189/jlb.0907611. Epub 2008 Feb 19. J Leukoc Biol. 2008. PMID: 18285406
-
Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells.Int Immunopharmacol. 2009 Jul;9(7-8):937-48. doi: 10.1016/j.intimp.2009.03.021. Epub 2009 Apr 9. Int Immunopharmacol. 2009. PMID: 19362167
-
Activities of granulocyte-macrophage colony-stimulating factor and interleukin-3 on monocytes.Am J Hematol. 2004 Apr;75(4):179-89. doi: 10.1002/ajh.20010. Am J Hematol. 2004. PMID: 15054806
-
[Biological properties of interleukin 18].Pol Merkur Lekarski. 2004 Mar;16(93):279-81. Pol Merkur Lekarski. 2004. PMID: 15190609 Review. Polish.
-
Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells.Immunol Rev. 2008 Apr;222:162-79. doi: 10.1111/j.1600-065X.2008.00602.x. Immunol Rev. 2008. PMID: 18364001 Review.
Cited by
-
CD66b+ monocytes represent a proinflammatory myeloid subpopulation in cancer.Cancer Immunol Immunother. 2021 Jan;70(1):75-87. doi: 10.1007/s00262-020-02656-y. Epub 2020 Jul 6. Cancer Immunol Immunother. 2021. PMID: 32632664 Free PMC article.
-
Tumor and microenvironment modification during progression of murine orthotopic bladder cancer.Clin Dev Immunol. 2011;2011:865684. doi: 10.1155/2011/865684. Epub 2011 Oct 13. Clin Dev Immunol. 2011. PMID: 22013484 Free PMC article.
-
Tumor-associated macrophages and stromal TNF-α regulate collagen structure in a breast tumor model as visualized by second harmonic generation.J Biomed Opt. 2013 Aug;18(8):86003. doi: 10.1117/1.JBO.18.8.086003. J Biomed Opt. 2013. PMID: 23912760 Free PMC article.
-
The density of macrophages in the invasive front is inversely correlated to liver metastasis in colon cancer.J Transl Med. 2010 Feb 8;8:13. doi: 10.1186/1479-5876-8-13. J Transl Med. 2010. PMID: 20141634 Free PMC article.
-
Immunotherapeutic modulation of the suppressive liver and tumor microenvironments.Int Immunopharmacol. 2011 Jul;11(7):879-89. doi: 10.1016/j.intimp.2010.12.024. Epub 2011 Jan 15. Int Immunopharmacol. 2011. PMID: 21241810 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous